Tag: Lonza

Lonza boosts manufacturing capabilities in USA

Lonza, a Swiss chemicals and biotechnology, company announced the expansion of its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in USA.

Lonza and Denali Therapeutics teamed up to develop biologic medicines

lonza building
Lonza Pharma & Biotech and Denali Therapeutics announced an exclusive strategic partnership on Denali’s biologic pipeline products for neurodegenerative diseases

New software from Lonza will provide regulatory guidance for scientists

good laboratory practice
Lonza’s MODA-EM Version 3.3 software enables microbiology Quality Control laboratories to comply with new regulatory guidelines

Lonza launches new R&D Collaborative Innovation Center in Israel

Lonza announced the establishment of the Lonza Collaborative Innovation Center (CIC) in the new Life Science Park in the outskirts of Haifa, Israel

Lonza widens its drug manufacturing capabilities

lonza building
Swiss pharmaceutical company, Lonza, announced that its Pharma & Biotech segment is expanding its footprint for Parenteral Dosage Form development with a further build-out of its Drug Product Services

Lonza bought Micro-Macinazione to keep up API development challenge

lonza building
Lonza has acquired Micro-Macinazione, one of Europe’s leading contract manufacturers providing micronization of active ingredients for the pharmaceutical and fine chemical industries